QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in
NASDAQ:ENOB

Enochian Biosciences News Headlines

$3.93
-0.03 (-0.76 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.87
Now: $3.93
$4.06
50-Day Range
$3.02
MA: $3.68
$4.51
52-Week Range
$1.95
Now: $3.93
$13.43
Volume208,007 shs
Average Volume162,822 shs
Market Capitalization$187.71 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5

Headlines

Enochian Biosciences (NASDAQ ENOB) News Headlines Today

Source:
SourceHeadline
Comparing Galapagos (NASDAQ:GLPG) and Enochian Biosciences (NASDAQ:ENOB)Comparing Galapagos (NASDAQ:GLPG) and Enochian Biosciences (NASDAQ:ENOB)
americanbankingnews.com - February 25 at 1:04 PM
Enochian Biosciences (NASDAQ:ENOB) Trading 5.2% Higher Enochian Biosciences (NASDAQ:ENOB) Trading 5.2% Higher
americanbankingnews.com - February 16 at 9:42 PM
Enochian Biosciences (NASDAQ:ENOB) Trading 15.8% Higher Enochian Biosciences (NASDAQ:ENOB) Trading 15.8% Higher
americanbankingnews.com - February 9 at 7:20 PM
Dow Jones U.S. Total Stock Market IndexDow Jones U.S. Total Stock Market Index
wsj.com - November 28 at 8:58 PM
What You Need To Know About Enochian Biosciences, Inc.s (NASDAQ:ENOB) Investor CompositionWhat You Need To Know About Enochian Biosciences, Inc.'s (NASDAQ:ENOB) Investor Composition
finance.yahoo.com - November 1 at 1:54 PM
Enochian Biosciences, Inc. Common Stock (ENOB)Enochian Biosciences, Inc. Common Stock (ENOB)
nasdaq.com - October 30 at 11:03 PM
Enochian Biosciences IncEnochian Biosciences Inc
www.reuters.com - July 30 at 5:42 PM
Distinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory BoardDistinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory Board
finance.yahoo.com - July 27 at 8:14 AM
Enochian Biosciences -3.8% on filing to offer sharesEnochian Biosciences -3.8% on filing to offer shares
seekingalpha.com - July 13 at 10:25 PM
Heres Why Small-Cap Biopharma Enochian Is Surging HigherHere's Why Small-Cap Biopharma Enochian Is Surging Higher
feeds.benzinga.com - June 8 at 1:20 PM
Mid-Day Market Update: Crude Oil Down Over 3%; Enochian Biosciences Shares Spike HigherMid-Day Market Update: Crude Oil Down Over 3%; Enochian Biosciences Shares Spike Higher
www.benzinga.com - June 8 at 1:05 PM
Enochian Bios HIV Treatment Is on Its Way With the FDAEnochian Bio's HIV Treatment Is on Its Way With the FDA
247wallst.com - June 8 at 1:05 PM
Enochian Biosciences up big on advancement of potential HIV cureEnochian Biosciences up big on advancement of potential HIV cure
seekingalpha.com - June 8 at 1:05 PM
Stock Alert: Enochian Biosciences Soars 140%Stock Alert: Enochian Biosciences Soars 140%
www.nasdaq.com - June 8 at 1:05 PM
Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIVEnochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV
finance.yahoo.com - June 8 at 8:05 AM
MacroGenics Reports Data, And Other News: The Good, Bad And Ugly Of BiopharmaMacroGenics Reports Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - May 16 at 11:33 AM
Company News for May 14, 2020Company News for May 14, 2020
finance.yahoo.com - May 14 at 12:00 PM
Enochian Bio up 24% after data presentations on HIV & HBV cell therapiesEnochian Bio up 24% after data presentations on HIV & HBV cell therapies
seekingalpha.com - May 13 at 3:58 PM
Enochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV CuresEnochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV Cures
finance.yahoo.com - May 13 at 9:43 AM
Is Enochian Biosciences (NASDAQ:ENOB) In A Good Position To Deliver On Growth Plans?Is Enochian Biosciences (NASDAQ:ENOB) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - April 23 at 12:22 PM
Enochian Biosciences, Inc.: Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”Enochian Biosciences, Inc.: Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”
www.bloomberg.com - March 5 at 2:29 PM
Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIVEnochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV
finance.yahoo.com - February 24 at 7:40 AM
Enochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potential Treatment or CureEnochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potential Treatment or Cure
finance.yahoo.com - February 3 at 10:49 AM
Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the appointment of two board members:Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the appointment of two board members:
finance.yahoo.com - January 6 at 9:28 AM
Enochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory BoardEnochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory Board
www.bloomberg.com - December 30 at 9:58 PM
Enochian Biosciences Announces Scientific Presentation of a Novel Approach to Potentially Cure Hepatitis B VirusEnochian Biosciences Announces Scientific Presentation of a Novel Approach to Potentially Cure Hepatitis B Virus
finance.yahoo.com - December 10 at 8:35 AM
The Enochian Biosciences Story Has Just Gotten Even More BizarreThe Enochian Biosciences Story Has Just Gotten Even More Bizarre
seekingalpha.com - December 5 at 12:57 PM
Enochian Bio +18% premarket on acquiring exclusive license for HBVEnochian Bio +18% premarket on acquiring exclusive license for HBV
seekingalpha.com - November 25 at 9:16 AM
Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus TreatmentEnochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus Treatment
finance.yahoo.com - November 25 at 9:16 AM
Enochain Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Enochain Biosciences Inc. To Contact The FirmEnochain Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Enochain Biosciences Inc. To Contact The Firm
finance.yahoo.com - November 21 at 1:37 PM
Enochian Biosciences Is A House Of Cards - The Pipeline Is Entirely Pre-Clinical And Management Has A Questionable HistoryEnochian Biosciences Is A House Of Cards - The Pipeline Is Entirely Pre-Clinical And Management Has A Questionable History
seekingalpha.com - November 20 at 1:46 AM
The Curious Case Of Enochian Biosciences: Value Out Of Thin Air - Price Target $1The Curious Case Of Enochian Biosciences: Value Out Of Thin Air - Price Target $1
seekingalpha.com - November 4 at 10:39 AM
Were Not Very Worried About Enochian Biosciencess (NASDAQ:ENOB) Cash Burn RateWe're Not Very Worried About Enochian Biosciences's (NASDAQ:ENOB) Cash Burn Rate
finance.yahoo.com - October 26 at 1:54 PM
We're Not Very Worried About Enochian Biosciences's (NASDAQ:ENOB) Cash Burn RateWe're Not Very Worried About Enochian Biosciences's (NASDAQ:ENOB) Cash Burn Rate
finance.yahoo.com - October 26 at 1:54 PM
Enochian BioSciences Inventor Named to Two Important Scientific CommitteesEnochian BioSciences Inventor Named to Two Important Scientific Committees
finance.yahoo.com - June 3 at 10:13 AM
Enochian Biosciences (NASDAQ:ENOB) Shareholders Have Enjoyed A 37% Share Price GainEnochian Biosciences (NASDAQ:ENOB) Shareholders Have Enjoyed A 37% Share Price Gain
finance.yahoo.com - April 29 at 3:32 PM
Successful Treatment of “London Patient” Underscores Clinical Potential of Enochian Biosciences’ Gene Modified Cellular Therapy for HIVSuccessful Treatment of “London Patient” Underscores Clinical Potential of Enochian Biosciences’ Gene Modified Cellular Therapy for HIV
finance.yahoo.com - March 7 at 3:27 PM
Enochian Bio up 19% on investor updateEnochian Bio up 19% on investor update
seekingalpha.com - February 11 at 3:21 PM
4 Healthcare Stocks Looking To Start February Off Strong4 Healthcare Stocks Looking To Start February Off Strong
finance.yahoo.com - February 1 at 3:20 PM
Monday 1/14 Insider Buying Report: AVK, ENOBMonday 1/14 Insider Buying Report: AVK, ENOB
www.nasdaq.com - January 14 at 3:18 PM
Enochian Biosciences Inc.Enochian Biosciences Inc.
www.barrons.com - January 11 at 3:17 PM
Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-ChairEnochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair
finance.yahoo.com - January 7 at 3:17 PM
How Much Of Enochian Biosciences Inc. (NASDAQ:ENOB) Do Insiders Own?How Much Of Enochian Biosciences Inc. (NASDAQ:ENOB) Do Insiders Own?
finance.yahoo.com - January 4 at 9:48 AM
Enochian Biosciences to Present at Biotech Showcase 2019Enochian Biosciences to Present at Biotech Showcase 2019
finance.yahoo.com - December 24 at 3:29 PM
Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”
finance.yahoo.com - December 24 at 3:29 PM
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.